Number of the records: 1

kapecitabín

SYS		d000069287
LBL		00000nz--a2200181n--4500
005		20250606221744.4
008		160101\|\|\|anznnbabn-----------\|-a\|a------
040		$b slo $a BA006 $d BA006
065		$a D03.383.742.680.245.500.425
065		$a D03.383.742.698.875.404.425
065		$a D13.570.230.329.313
065		$a D13.570.685.245.500.425
066		$a 01 $c 03
150		$a kapecitabín $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo
550		$7 sllk_us_auth*d000964 $Y Antimetabolites, Antineoplastic $w P $a antimetabolity protinádorové
665		$a 2016 (1998) $2 eng
680	9-	$i A deoxycytidine derivative and fluorouracil PRODRUG that is used as an ANTINEOPLASTIC ANTIMETABOLITE in the treatment of COLON CANCER; BREAST CANCER and GASTRIC CANCER. $2 eng
750	-2	$a Capecitabine $2 eng
980		$x M

Number of the records: 1